Hidden Risks: How HIV Meds Can Clash with Common Steroid Injections
A new study reveals a concerning interaction between common HIV medications and steroid injections, spotlighting the risk of adrenal insufficiency. Learn how to protect your health.
A new study reveals a concerning interaction between common HIV medications and steroid injections, spotlighting the risk of adrenal insufficiency. Learn how to protect your health.
Explore the growing threat of carbapenem-resistant Klebsiella pneumoniae in Iraqi hospitals, the emergence of NDM-1, and how infection control practices can help.
Discover how CD82, a key molecule in cell adhesion, can help regulate the Wnt signaling pathway and potentially prevent cancer metastasis. A comprehensive look into CD82's multifaceted functions and its therapeutic potential.
Occupational lung diseases are more common than you think, but often go undiagnosed. Learn how radiologists can play a key role in identifying these hidden threats and ensuring workers receive the care they deserve.
Discover how a novel simulation model is transforming the landscape of heart disease prediction, offering insights into the true value of biomarkers and paving the way for more effective prevention strategies.
Confused by eye symptoms? This guide simplifies ophthalmology, explaining common eye conditions, their causes, and diagnostic methods. Perfect for anyone seeking clarity on their eye health.
Anastomotic leaks are a major concern in colon surgery. Discover proactive strategies for prevention and effective management of leaks, enhancing patient outcomes and surgical success.
Explore the surprising link between environmental toxins and fertility. Learn how endocrine disruptors impact reproductive health, with new research providing critical insights.
Explore the highlights of the 2018 BACCN Conference, from inspiring keynote speakers and hands-on simulations to awards and social media engagement. Discover how this event celebrated critical care nurses and fostered innovation in the field.
Discover how low-dose ponatinib can safely and effectively manage relapsed Philadelphia chromosome-positive leukemia, paving the way for successful allogeneic hematopoietic cell transplantation (HCT).